Understand any stock in simple English
Ivoclar makes the ceramics, filling materials, and false teeth that dentists and dental labs use to repair and replace people's teeth.
Ivoclar Vivadent is a dental products company. It sells the stuff that goes into your mouth when you get a crown, a filling, or a set of dentures โ and it sells the equipment and know-how that dental labs need to make those things. Its customers are not regular people shopping online. They are dentists and dental technicians, the people who actually do the repair work.
The business breaks into a few main areas. One is ceramics and prosthetics: the tooth-colored materials and milling machines used to make crowns, bridges, and artificial teeth that look and behave like the real thing. Another is filling materials and adhesives โ the composites and bonding agents a dentist uses to patch a cavity or glue a restoration in place. A third is equipment and digital dentistry, including scanners and furnaces that let a lab design and build a tooth restoration on a screen instead of by hand. The thread running through all of it is that dentists want restorations that last, look natural, and are quick to place, and labs want materials that are predictable to work with. Ivoclar sells that reliability, along with training and support, which is why dentists and technicians tend to stay loyal to a brand once they trust it. The company is headquartered in Schaan, Liechtenstein, a tiny Alpine country between Switzerland and Austria, and it operates worldwide with manufacturing and subsidiaries across Europe, the Americas, and Asia. It is privately held, so you cannot buy its shares, and it does not publish the kind of quarterly earnings reports a public company would. That privacy matters: it can invest in long-term research and global distribution without answering to Wall Street every three months. Its main rivals are the big dental-material makers โ Dentsply Sirona, Envista, and 3M's dental business โ plus a long tail of smaller ceramic and composite specialists.
The dental market is steady rather than explosive. People keep needing cavities filled and teeth replaced, and as populations age and more people in developing countries get access to dental care, demand grinds upward. But it is also a market where a bad batch of material or a failed restoration can hurt a reputation fast, so quality control and clinical evidence are the real moat. Ivoclar's bet is that if it keeps winning the trust of the technician holding the drill and the dentist chairside, the replacement-cycle business takes care of itself.
Saved answer ยท last researched 16 Nov 2026
One Liechtenstein company holds over 14% of the world's zirconia dental materials market
Zirconia is the tough white ceramic used for crowns and bridges, and Ivoclar sells more of it than any rival. Its share of that market came in above 14% in 2025, ahead of Dentsply Sirona, 3M, Kuraray and GC. The top five players together hold only about 51%, so no single firm controls the field. For a company based in a country of about 40,000 people, that is a strong spot in a market dentists buy from every day. Source: Brevintel, data from 2025
In Zurich, Switzerland, a small company called Ramsperger and Co. set out to make artificial ceramic teeth. That was the seed of what would one day become a leading international dental company.
During the Depression, the company moved to Schaan, Liechtenstein, drawn by tax-free incentives. The headquarters has stayed there ever since, so a business born in Zurich became a Liechtenstein company for good.
After Adolf Schneider took over the firm, it got a new name: Ivoclar. The Vivadent part came later, and only in 2001 did the two names join into Ivoclar Vivadent.
Ivoclar bought Williams Gold Refining Co., a leading maker of precious-metal dental materials. The move gave it a much stronger foothold in the fast-growing North American market, and it set the pattern of growing by buying good businesses.
The company launched IPS Empress, the world's first pressable ceramic, a product that shook up the dental industry. Tetric technology followed a year later, opening a new era of tooth-colored restoratives, the fillings and repairs that look like real teeth.
Next came IPS e.max, a lithium disilicate glass-ceramic. It quickly became the reference standard for dental glass-ceramics and turned into one of the company's core products.
The company acquired Kapanu, a developer of digital solutions for dentistry. That led to IvoSmile, an augmented-reality consultation app launched the following year, which let dentists show patients what their smile could look like.
Diego Gabathuler became CEO, taking over from Robert Ganley, who had led the company since 2003. At the same time, Christoph Zeller stepped back as board president after 29 years, with Helmut Schuster succeeding him, so both the top job and the board changed hands.
The company dropped the Vivadent part of its name and rebranded simply as Ivoclar. A long name built up over years of deals gave way to one short word.
Ivoclar celebrated its 100th anniversary and opened a new head office building in Schaan. Markus Heinz also succeeded Diego Gabathuler as CEO, so the centenary year brought both a milestone and a change at the top.
The company signed a deal with Shanghai's Xinzhuang Industrial Park for a first-phase automated dental device production line. It was the first time the group moved manufacturing to mainland China, filling a gap in its China presence.